PEPD is a pivotal regulator of p53 tumor suppressor

被引:24
|
作者
Yang, Lu [1 ]
Li, Yun [1 ,2 ]
Bhattacharya, Arup [1 ]
Zhang, Yuesheng [1 ,3 ]
机构
[1] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA
来源
NATURE COMMUNICATIONS | 2017年 / 8卷
关键词
PROTEIN-PROTEIN INTERACTION; GROWTH-FACTOR RECEPTOR; PROLINE-RICH DOMAIN; PROLIDASE DEFICIENCY; SH3; DOMAIN; EXPRESSION; APOPTOSIS; ENZYME; TRANSACTIVATION; CHEMOTHERAPY;
D O I
10.1038/s41467-017-02097-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
p53 tumor suppressor responds to various cellular stresses and regulates cell fate. Here, we show that peptidase D (PEPD) binds and suppresses over half of nuclear and cytoplasmic p53 under normal conditions, independent of its enzymatic activity. Eliminating PEPD causes cell death and tumor regression due to p53 activation. PEPD binds to the proline-rich domain in p53, which inhibits phosphorylation of nuclear p53 and MDM2-mediated mitochondrial translocation of nuclear and cytoplasmic p53. However, the PEPD-p53 complex is critical for p53 response to stress, as stress signals doxorubicin and H2O2 each must free p53 from PEPD in order to achieve robust p53 activation, which is mediated by reactive oxygen species. Thus, PEPD stores p53 for the stress response, but this also renders cells dependent on PEPD for survival, as it suppresses p53. This finding provides further understanding of p53 regulation and may have significant implications for the treatment of cancer and other diseases.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] PEPD is a pivotal regulator of p53 tumor suppressor
    Lu Yang
    Yun Li
    Arup Bhattacharya
    Yuesheng Zhang
    Nature Communications, 8
  • [2] PEPD is an essential regulator of p53 tumor suppressor
    Yang, Lu
    Li, Yun
    Bhattacharya, Arup
    Zhang, Yuesheng
    CANCER RESEARCH, 2018, 78 (13)
  • [3] disrupting binding of p53 mutants to PEPD unleashes their tumor suppressor activities.
    Yang, Lu
    CANCER RESEARCH, 2021, 81 (13)
  • [4] The p53 tumor suppressor as a regulator of innate immunity genes
    Shatz, Maria
    Menendez, Daniel
    Resnick, Michael
    CANCER RESEARCH, 2009, 69
  • [5] The p53 tumor suppressor: Critical regulator of life & death in cancer
    D. E. Fisher
    Apoptosis, 2001, 6 : 7 - 15
  • [6] The p53 tumor suppressor: Critical regulator of life & death in cancer
    Fisher, DE
    APOPTOSIS, 2001, 6 (1-2) : 7 - 15
  • [7] CARF: An emerging regulator of p53 tumor suppressor and senescence pathway
    Cheung, Caroline T. Y.
    Hasan, Md. Kamrul
    Widodo, Nashi
    Kaul, Sunil C.
    Wadhwa, Renu
    MECHANISMS OF AGEING AND DEVELOPMENT, 2009, 130 (1-2) : 18 - 23
  • [8] MDM2 - master regulator of the p53 tumor suppressor protein
    Momand, J
    Wu, HH
    Dasgupta, G
    GENE, 2000, 242 (1-2) : 15 - 29
  • [9] The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways
    Yu, CL
    Driggers, P
    BarreraHernandez, G
    Nunez, SB
    Segars, JH
    Cheng, SY
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 239 (02) : 617 - 620
  • [10] The p53 tumor suppressor targets a novel regulator of G protein signaling
    Buckbinder, L
    VelascoMiguel, S
    Chen, Y
    Xu, NZ
    Talbott, R
    Gelbert, L
    Gao, JZ
    Seizinger, BR
    Gutkind, JS
    Kley, N
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) : 7868 - 7872